Bill

Bill > A181


NJ A181

NJ A181
Expands epinephrine administration mechanisms permitted in schools.


summary

Introduced
01/13/2026
In Committee
01/13/2026
Crossed Over
Passed
Dead

Introduced Session

2026-2027 Regular Session

Bill Summary

This bill modifies current law regulating the method in which epinephrine is administered in schools during emergency circumstances where a pupil is experiencing anaphylaxis. Specifically, the bill amends current law requiring the use of a pre-filled auto-injector mechanism to administer epinephrine in a school setting to allow any FDA approved epinephrine administration mechanism to be used during an in-school anaphylaxis emergency.

AI Summary

This bill expands the types of epinephrine administration devices that schools can use to treat students experiencing anaphylaxis, a severe allergic reaction. Previously, current law only permitted the use of a pre-filled auto-injector, a common type of device that automatically injects a dose of epinephrine. This bill amends that law to allow any epinephrine administration mechanism that has been approved by the U.S. Food and Drug Administration (FDA) to be used in school emergency situations. This change aims to provide schools with more options for administering life-saving medication during anaphylaxis emergencies, while still requiring parental consent, physician orders, and clear liability protections for the school and its employees.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Introduced, Referred to Assembly Health Committee (on 01/13/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...